Evaluation of Blood Flow Characteristics in Glaucoma Using Optical Coherence Tomography Angiography (OCT-A).
NCT ID: NCT02757677
Last Updated: 2022-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
200 participants
OBSERVATIONAL
2015-12-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Choroidal Blood Flow Response to Hand-grip Test in Progressive Glaucoma
NCT00284440
Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma
NCT06274593
Functional and Structural Imaging for Glaucoma
NCT01957267
Advanced Glaucoma Progression Study
NCT01742819
Blood Flow of Ophthalmic Artery and Glaucoma
NCT02656979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Longitudinal arm
Evaluate optic nerve head blood flow using the new OCT-A software in surgically and medically treated glaucoma patients and in different types of glaucoma
Optical Coherence Tomography based Angiography
A contrast-free, noninvasive technology to identify blood vessels in the eye
24-h Intraocular pressure (IOP) arm
Evaluate the correlation between circadian IOP changes and optic nerve head blood flow using the new OCT-A software
Optical Coherence Tomography based Angiography
A contrast-free, noninvasive technology to identify blood vessels in the eye
Surgery arm
Evaluate blood flow using the new OCT-A software in surgically treated glaucoma patients
Optical Coherence Tomography based Angiography
A contrast-free, noninvasive technology to identify blood vessels in the eye
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical Coherence Tomography based Angiography
A contrast-free, noninvasive technology to identify blood vessels in the eye
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented glaucomatous visual field damage (in the previous 12 months with mean defect (MD) \> 2.0 dB)
* Structural and/or functional glaucomatous damage
* Have given written informed consent, prior to any investigational procedures
Exclusion Criteria
* Patients not able to understand the character and individual consequences of the investigation
* Participation in other clinical research within the last 4 weeks
* Other diseases that may cause visual field loss or optic disc abnormalities
* Refractive error of \> +3.00D or \< -7.00D
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Vision Network
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Kaweh Mansouri
dr. Kaweh Mansouri
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kaweh Mansouri, MD
Role: PRINCIPAL_INVESTIGATOR
Glaucoma center, Montchoisi clinic, Swiss vision network
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glaucoma center, Montchoisi clinic
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GR-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.